Land: Storbritannia
Språk: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Prednisolone
Logixx Pharma Solutions Ltd
H02AB06
Prednisolone
1mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06030200; GTIN: 5060347610015
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT PREDNISOLONE 1MG/ML ORAL SOLUTION Prednisolone sodium phosphate _ _ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. - PREDNISOLONE IS A STEROID MEDICINE, prescribed for many different conditions, including serious illnesses. - YOU NEED TO TAKE IT REGULARLY to get the maximum benefit. - DO NOT STOP TAKING THIS MEDICINE without talking to your doctor. You may need to reduce the dose gradually. - Prednisolone Dompé can cause side effects in some people (read section 4 below). SOME SIDE EFFECTS such as mood changes (feeling depressed or “high”) or stomach problems can happen straight away. If you feel unwell in any way, keep taking your oral solution, but SEE YOUR DOCTOR STRAIGHT AWAY. - SOME SIDE EFFECTS ONLY HAPPEN AFTER WEEKS OR MONTHS. These include weakness of arms and legs or developing a rounder face (read section 4 for more information). - KEEP AWAY FROM PEOPLE WHO HAVE CHICKEN-POX OR SHINGLES, if you have never had them. They could affect you severely. If you do come into contact with chicken-pox or shingles, SEE YOUR DOCTOR STRAIGHT AWAY. Now read the rest of this leaflet. It includes other important information on the safe and effective use of this medicine that may be especially important for you. WHAT IS IN THIS LEAFLET 1. What Prednisolone Dompé Oral Solution is and what it is used for 2. What you need to know before you take Prednisolone Dompé Oral Solution 3. How to take Prednisolone Dompé Oral Solution 4. Possible side effects 5. How to store Prednisolone Dompé Oral Solutio Les hele dokumentet
OBJECT 1 PREDNISOLONE DOMPE 1.0 MG/ML ORAL SOLUTION Summary of Product Characteristics Updated 18-May-2018 | Logixx Pharma Solutions Ltd 1. Name of the medicinal product Prednisolone Dompé 1.0 mg/ml oral solution 2. Qualitative and quantitative composition The active ingredient of Prednisolone Dompé is prednisolone as the sodium phosphate ester. Each 1 ml oral solution contains 1 mg prednisolone (as sodium phosphate). Each 5 ml single-dose container contains 5 mg of prednisolone (as sodium phosphate). Each 5 ml single-dose container contains 0.5 mmole sodium per dose. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Oral Solution 4. Clinical particulars 4.1 Therapeutic indications Rheumatological disorders and connective tissue diseases such as: • rheumatoid arthritis (for primary chronic disease and maintenance therapy) • systemic lupus erythematosus (non-organ threatening disease) • mild-moderate juvenile dermatomyositis Severe or debilitating allergic conditions, not treatable in a conventional manner such as: • bronchial asthma in children • bronchial asthma in adults (for maintenance therapy) Sarcoidosis in children and for maintenance therapy in adults Acquired haemolytic anaemia (autoimmune, for maintenance therapy) 4.2 Posology and method of administration Posology The lowest dosage that will produce an acceptable result should be used (See section 4.4); when it is possible to reduce the dosage, this must be accomplished by stages. During prolonged therapy any intercurrent illness, trauma or surgical procedure will require a temporary increase in dosage; if corticosteroids have been stopped following prolonged therapy they may need to be temporarily re- introduced. The medicinal product should preferably be taken as a single dose in the morning. However, divided daily dosages may be employed if required. _NOTE TO THE PRESCRIBER:_ This 5 ml single-dose unit presentation should not be prescribed for doses exceeding 30 mg daily, because opening more than 6 containers in a da Les hele dokumentet